Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive coloniza...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2018-08-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/84 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860315516829696 |
---|---|
author | V. T. Ivashkin N. D. Yushchuk I. V. Mayev Tatyana L Lapina Ye. A. Poluektova O. S. Shifrin A. S. Tertychny A. S. Trukhmanov A. A. Sheptulin Ye. K. Baranskaya O. S. Lyashenko K. V. Ivashkin |
author_facet | V. T. Ivashkin N. D. Yushchuk I. V. Mayev Tatyana L Lapina Ye. A. Poluektova O. S. Shifrin A. S. Tertychny A. S. Trukhmanov A. A. Sheptulin Ye. K. Baranskaya O. S. Lyashenko K. V. Ivashkin |
author_sort | V. T. Ivashkin |
collection | DOAJ |
description | Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive colonization of C. difficile which toxins cause colonic inflammation and damage. C. difficile toxins A and B are major virulence factors causing damage of intestinal wall and inflammation due to damage of intestinal epithelial barrier, induction of proinflammatory cytokines, apoptosis and a necrosis of epithelial cells. Current epidemiologic trends of C. difficile-associated disease are characterized by growth of both inpatient and community-acquired morbidity, expansion of risk groups, increase in number of more severe cases including those, caused by more virulent BI/NAP1/027strain, tendency to relapsing, increase in lethal outcomes. C. difficile infection is the most common cause of intrahospital diarrhea leading to significant mortality. Risk factors of C. difficile-associated include antibacterial therapy, hospital admission, elderly age, comorbidity and immunosuppressive treatment. At the present time several laboratory methods for diagnosis of Clostridial infection exist: fecal ELISA test for toxins A and B, PCR, test for C. difficile glutamate dehydrogenase. Detection of densely adhered to underlying mucosa greenish or creamy deposits (pseudomembranes) is the endoscopical marker of severe C. difficile-associated disease i.e. pseudomembranous colitis. C. difficile-associated disease treatment includes vancomycin and metronidazole, the choice of drug and dose depends on disease severity. Significance of sorbents and probiotics in patient management is under discussion. Prophylaxis requires rational application of antibiotics, decrease, whenever possible, of terms of hospital stay, timely diagnosis and observance of sanitary and epidemiologic rules in medical institutions. Conclusion. Epidemiologic growth, risk of significant morbidity made C. difficile-associated disease a socially important disease. The present guidelines direct the doctor to correct diagnosis and adequate treatment of C. difficile infection. |
format | Article |
id | doaj-art-e6831bd74af34c6eac9b201825e95f69 |
institution | Kabale University |
issn | 1382-4376 2658-6673 |
language | Russian |
publishDate | 2018-08-01 |
publisher | Gastro LLC |
record_format | Article |
series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
spelling | doaj-art-e6831bd74af34c6eac9b201825e95f692025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01265566510.22416/1382-4376-2016-5-56-6584Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological associationV. T. Ivashkin0N. D. Yushchuk1I. V. Mayev2Tatyana L Lapina3Ye. A. Poluektova4O. S. Shifrin5A. S. Tertychny6A. S. Trukhmanov7A. A. Sheptulin8Ye. K. Baranskaya9O. S. Lyashenko10K. V. Ivashkin11Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»State educational government-financed institution of higher professional education «Yevdokimov Moscow State University of Medicine and Dentistry»State educational government-financed institution of higher professional education «Yevdokimov Moscow State University of Medicine and Dentistry»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive colonization of C. difficile which toxins cause colonic inflammation and damage. C. difficile toxins A and B are major virulence factors causing damage of intestinal wall and inflammation due to damage of intestinal epithelial barrier, induction of proinflammatory cytokines, apoptosis and a necrosis of epithelial cells. Current epidemiologic trends of C. difficile-associated disease are characterized by growth of both inpatient and community-acquired morbidity, expansion of risk groups, increase in number of more severe cases including those, caused by more virulent BI/NAP1/027strain, tendency to relapsing, increase in lethal outcomes. C. difficile infection is the most common cause of intrahospital diarrhea leading to significant mortality. Risk factors of C. difficile-associated include antibacterial therapy, hospital admission, elderly age, comorbidity and immunosuppressive treatment. At the present time several laboratory methods for diagnosis of Clostridial infection exist: fecal ELISA test for toxins A and B, PCR, test for C. difficile glutamate dehydrogenase. Detection of densely adhered to underlying mucosa greenish or creamy deposits (pseudomembranes) is the endoscopical marker of severe C. difficile-associated disease i.e. pseudomembranous colitis. C. difficile-associated disease treatment includes vancomycin and metronidazole, the choice of drug and dose depends on disease severity. Significance of sorbents and probiotics in patient management is under discussion. Prophylaxis requires rational application of antibiotics, decrease, whenever possible, of terms of hospital stay, timely diagnosis and observance of sanitary and epidemiologic rules in medical institutions. Conclusion. Epidemiologic growth, risk of significant morbidity made C. difficile-associated disease a socially important disease. The present guidelines direct the doctor to correct diagnosis and adequate treatment of C. difficile infection.https://www.gastro-j.ru/jour/article/view/84clostridium difficile-ассоци иро-ванная болезньэпидемиологияпатогенезклини-кадиагностикалечениепрофилактика |
spellingShingle | V. T. Ivashkin N. D. Yushchuk I. V. Mayev Tatyana L Lapina Ye. A. Poluektova O. S. Shifrin A. S. Tertychny A. S. Trukhmanov A. A. Sheptulin Ye. K. Baranskaya O. S. Lyashenko K. V. Ivashkin Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association Российский журнал гастроэнтерологии, гепатологии, колопроктологии clostridium difficile-ассоци иро-ванная болезнь эпидемиология патогенез клини-ка диагностика лечение профилактика |
title | Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association |
title_full | Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association |
title_fullStr | Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association |
title_full_unstemmed | Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association |
title_short | Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association |
title_sort | diagnostics and treatment of clostridium difficile associated disease guidelines of the russian gastroenterological association |
topic | clostridium difficile-ассоци иро-ванная болезнь эпидемиология патогенез клини-ка диагностика лечение профилактика |
url | https://www.gastro-j.ru/jour/article/view/84 |
work_keys_str_mv | AT vtivashkin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT ndyushchuk diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT ivmayev diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT tatyanallapina diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT yeapoluektova diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT osshifrin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT astertychny diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT astrukhmanov diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT aasheptulin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT yekbaranskaya diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT oslyashenko diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation AT kvivashkin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation |